© 2001 European Society of Cardiology
Isolated diastolic heart failure as a cause of breathlessness in the community: the Arbroath study
a Department of Clinical Pharmacology and Therapeutics, University of Dundee, Ninewells Hospital and Medical School Dundee DD1 9SY, Scotland, UK
b Department of Cardiology, University of Dundee, Ninewells Hospital and Medical School Dundee DD1 9SY, Scotland, UK
c Medicines Monitoring Unit, University of Dundee, Ninewells Hospital and Medical School Dundee DD1 9SY, Scotland, UK
d The Medical Centre Arbroath, Scotland, UK
* Corresponding author. Cardiac Unit (7th Floor), Raigmore Hospital, Old Perth Road, Inverness IV2 3UJ, UK; tel.: +44-1463704000 ext. 5576, pager 7053; fax: +44-1463705463. E-mail address: robert.macfadyen{at}raigmore.scot.nhs.uk (R.J. MacFadyen).
 |
Abstract |
|---|
The aim of this study was to examine the prevalence of exercise limitation due to diastolic heart failure among patients felt to have cardiac breathlessness by their general medical practitioner but not referred to hospital. We found that 18% of patients had a simple investigated profile compatible with isolated diastolic dysfunction as a cause of their symptoms. Symptoms appeared to pre-date major cardiac events (infarction; stroke; arrhythmia) that dominated the subsequent clinical course. The patients in this group have adverse cardiovascular risk profiles. Obesity was a common co-morbidity which may impair detailed 2-D echocardiographic assessment.
Key Words: Community-managed breathlessness • Diagnoses • Impaired exercise capacity • Diastolic heart failure
Received April 28, 1999; Revised December 15, 1999; Accepted December 20, 1999
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  H. K. Parthasarathy, B. Pieske, M. Weisskopf, C. D. Andrews, P. Brunel, A. D. Struthers, and T. M. MacDonald A randomized, double-blind, placebo-controlled study to determine the effects of valsartan on exercise time in patients with symptomatic heart failure with preserved ejection fraction Eur J Heart Fail, October 1, 2009; 11(10): 980 - 989. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M D Thomas, K F Fox, D A Wood, J S R Gibbs, A J S Coats, M Y Henein, P A Poole-Wilson, and G C Sutton Echocardiographic features and brain natriuretic peptides in patients presenting with heart failure and preserved systolic function Heart, May 1, 2006; 92(5): 603 - 608. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. W. Nielsen, A. Sajedieh, F. Petersen, and J. Fischer Hansen Value of left ventricular filling parameters to predict mortality and functional class in patients with heart disease from the community Eur J Echocardiogr, March 1, 2005; 6(2): 85 - 91. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Gustafsson, C. B. Kragelund, C. Torp-Pedersen, M. Seibaek, H. Burchardt, D. Akkan, J. J. Thune, L. Kober, and for the DIAMOND study group Effect of obesity and being overweight on long-term mortality in congestive heart failure: influence of left ventricular systolic function Eur. Heart J., January 1, 2005; 26(1): 58 - 64. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. H. Lavietes, C. M. Gerula, K. G. Fless, N. S. Cherniack, and R. R. Arora Inspiratory Muscle Weakness in Diastolic Dysfunction Chest, September 1, 2004; 126(3): 838 - 844. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Banerjee, A. L. Clark, N. Nikitin, and J. G.F. Cleland Diastolic heart failure. Paroxysmal or chronic? Eur J Heart Fail, June 1, 2004; 6(4): 427 - 431. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. D. Thomas, K. F. Fox, A. J.S. Coats, and G. C. Sutton The epidemiological enigma of heart failure with preserved systolic function Eur J Heart Fail, March 1, 2004; 6(2): 125 - 136. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G Yip, M Wang, Y Zhang, J W H Fung, P Y Ho, and J E Sanderson Left ventricular long axis function in diastolic heart failure is reduced in both diastole and systole: time for a redefinition? Heart, February 1, 2002; 87(2): 121 - 125. [Abstract] [Full Text] [PDF]
|
|